Citadel Advisors’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $489K | Sell |
121,336
-300,126
| -71% | -$1.21M | ﹤0.01% | 4081 |
|
|
2025
Q1 | $1.15M | Sell |
421,462
-522,620
| -55% | -$1.43M | ﹤0.01% | 3131 |
|
|
2024
Q4 | $4.01M | Buy |
944,082
+772,910
| +452% | +$3.28M | ﹤0.01% | 1977 |
|
|
2024
Q3 | $503K | Buy |
171,172
+145,866
| +576% | +$429K | ﹤0.01% | 3784 |
|
|
2024
Q2 | $88.1K | Sell |
25,306
-221,213
| -90% | -$770K | ﹤0.01% | 5006 |
|
|
2024
Q1 | $703K | Buy |
246,519
+246,186
| +73,930% | +$702K | ﹤0.01% | 3548 |
|
|
2023
Q4 | $1.18K | Sell |
333
-126,829
| -100% | -$448K | ﹤0.01% | 5708 |
|
|
2023
Q3 | $329K | Buy |
127,162
+101,810
| +402% | +$264K | ﹤0.01% | 4174 |
|
|
2023
Q2 | $99.9K | Buy |
+25,352
| New | +$99.9K | ﹤0.01% | 4757 |
|
|
2023
Q1 | – | Sell |
-140,279
| Closed | -$502K | – | 5936 |
|
|
2022
Q4 | $502K | Buy |
140,279
+13,227
| +10% | +$47.4K | ﹤0.01% | 3841 |
|
|
2022
Q3 | $512K | Sell |
127,052
-15,054
| -11% | -$60.7K | ﹤0.01% | 4055 |
|
|
2022
Q2 | $634K | Buy |
142,106
+69,479
| +96% | +$310K | ﹤0.01% | 3903 |
|
|
2022
Q1 | $616K | Buy |
72,627
+55,854
| +333% | +$474K | ﹤0.01% | 4235 |
|
|
2021
Q4 | $148K | Buy |
16,773
+6,081
| +57% | +$53.7K | ﹤0.01% | 5668 |
|
|
2021
Q3 | $111K | Sell |
10,692
-175,365
| -94% | -$1.82M | ﹤0.01% | 5802 |
|
|
2021
Q2 | $1.95M | Buy |
186,057
+179,145
| +2,592% | +$1.88M | ﹤0.01% | 3245 |
|
|
2021
Q1 | $71K | Sell |
6,912
-302,509
| -98% | -$3.11M | ﹤0.01% | 5995 |
|
|
2020
Q4 | $3.43M | Buy |
+309,421
| New | +$3.43M | ﹤0.01% | 2084 |
|